logo
Share SHARE
FONT-SIZE Plus   Neg

Aduro BioTech Acquires GVAX Assets From BioSante Pharma - Quick Facts

Aduro BioTech Inc. announced the acquisition of all GVAX assets from BioSante Pharmaceuticals Inc. (BPAX), including intellectual property and cell lines.

Aduro previously licensed two GVAX vaccines, GVAX Pancreas and GVAX Prostate, for use in combination with its Listeria-based vaccines.

Aduro said that the new acquisition covers all uses and includes additional vaccines for multiple myeloma and breast and colon cancer and assumes rights to the existing license agreement for GVAX Melanoma.

Under its purchase agreement with BioSante, Aduro paid $1 million upfront and has committed to additional milestone and royalty payments after commercialization of GVAX product(s).

GVAX vaccines are based on human cancer cell lines that are genetically modified to secrete granulocyte-macrophage colony-stimulating factor (GM-CSF), an immune-stimulatory cytokine.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
General Mills has announced another expansion to its flour recall in response to four new illnesses that were linked to a possible E. Coli outbreak. The latest recall covers several varieties of Signature Kitchens and Gold Medal flour produced through February 10. General Mill had first announced... Google maps will be more easy to use with its latest update. Traffic information will be more visible with its new cleaner look. Starbucks baristas are now free to express their personal style at work under a new dress code announced by the world's largest specialty coffee retailer. Instead of the familiar solid black, white and khaki clothing underneath their iconic green aprons, baristas can now come for work in a range of colors and outfits that reflect their own personal tastes.
comments powered by Disqus
Follow RTT